The use of epigenetics in the treatment of leukaemia

Bookmark and Share
Published: 3 Aug 2010
Views: 6644
Dr Stephen Baylin, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
Dr Stephen Baylin speaks at an EHA 2010 press conference about the use of epigenetics to treat cancer. Dr Baylin explains what epigenetics is, talks about some epigenetic drugs that have been successful in treating myelodysplastic syndrome (MDS) and explains how administering these drugs at a lower dose can reduce the associated side effects while maintaining efficacy.